abstract |
A melatonin receptor agonist or partial agonist of formula (I): Wherein each of R 1 , R 2 , y, m, n and Ar is as defined and is described in the classes and subclasses herein. The compound shown by this is provided. The above compounds and compositions comprising this compound can be used to treat melatonin disorders. |